In vitro determination of anticryptosporidial activity of phytogenic extracts and compounds
- PMID: 22278729
- DOI: 10.1007/s00436-012-2824-y
In vitro determination of anticryptosporidial activity of phytogenic extracts and compounds
Abstract
Cryptosporidiosis caused by Cryptosporidium spp. is an important diarrhoeal disease observed in farm animals and humans, especially in young or immunocompromised individuals. A novel cell culture assay for testing extracts and pure compounds against Cryptosporidium parvum in 96-well microplate format was established and evaluated. It is based on previously described indirect fluorescent antibody techniques and was optimised for higher sample throughput. Rapid assessment of minimal inhibitory concentrations (MICs) was done by checking each well microscopically for the presence or absence of parasite stages. As a novelty, parasite development was quantified by enumeration of clusters of secondary infection (CSI), which typically appeared upon infection with a distinct parasite inoculum after a defined incubation time. Host cell (HCT-8) viability was measured by an integrated non-destructive water-soluble tetrazolium salt assay (WST-1), which facilitated discrimination of antiparasitic activity from possible cytotoxic effects of a test compound against the host cells. Host cell viability was regarded unimpaired when cultures had 75% or more viability when compared to control cultures without test substance. In this study, a maximum density of distinguishable CSI was obtained when cultures were infected with 2.5 × 10(3) oocysts and incubated for 48 h. The applicable inoculum has to be optimised for each batch of oocysts and before each experimental series. Parasite development was inhibited completely by monensin at 134 nM and silymarin at 50 mg/mL. These concentrations were non-toxic to the host cells and comparable to literature data. The percentages of parasite inhibition were determined for monensin and a 50% inhibitory concentration (IC(50)) of 36.6 nM (27.4-45.5) and a 90% inhibitory concentration of 65.9 nM (54.8-90.2) were calculated. The introduced assay is economic because relatively low parasite numbers may be used. If MICs are determined, evaluation is fast, as each well is viewed only briefly under the fluorescence microscope for presence or absence of CSI. Furthermore it is highly critical because only full parasite inhibition is assessed. Counting of CSI is more laborious and time-consuming, but it allows calculation of parasite inhibition rates and parameters like the half maximal inhibitory concentration (IC(50)). This assay shall be used to assess anticryptosporidial activities of various plant waste materials and by-products from the food and the pharmaceutical industries in the course of the EU project SAFEWASTES. Comparison with in vivo models should be performed to further corroborate the results. Automated evaluation by flow cytometry might facilitate higher sample throughput and reduce operator bias.
Similar articles
-
Effect of Ginsenoside-Rh2 and Curcurbitacin-B on Cryptosporidium parvum in vitro.Exp Parasitol. 2020 May;212:107873. doi: 10.1016/j.exppara.2020.107873. Epub 2020 Mar 9. Exp Parasitol. 2020. PMID: 32165146
-
In vitro inhibitory effects of plant-derived by-products against Cryptosporidium parvum.Parasite. 2016;23:41. doi: 10.1051/parasite/2016050. Epub 2016 Sep 14. Parasite. 2016. PMID: 27627637 Free PMC article.
-
Anti-protozoal activity of extracts from chicory (Cichorium intybus) against Cryptosporidium parvum in cell culture.Sci Rep. 2019 Dec 31;9(1):20414. doi: 10.1038/s41598-019-56619-0. Sci Rep. 2019. PMID: 31892721 Free PMC article.
-
Efficacy of chitosan, a natural polysaccharide, against Cryptosporidium parvum in vitro and in vivo in neonatal mice.Exp Parasitol. 2018 Nov;194:1-8. doi: 10.1016/j.exppara.2018.09.003. Epub 2018 Sep 17. Exp Parasitol. 2018. PMID: 30237052
-
Cryptic parasite revealed improved prospects for treatment and control of human cryptosporidiosis through advanced technologies.Adv Parasitol. 2011;77:141-73. doi: 10.1016/B978-0-12-391429-3.00007-1. Adv Parasitol. 2011. PMID: 22137584 Review.
Cited by
-
Discovery of Novel Anti-cryptosporidial Activities From Natural Products by in vitro High-Throughput Phenotypic Screening.Front Microbiol. 2019 Aug 29;10:1999. doi: 10.3389/fmicb.2019.01999. eCollection 2019. Front Microbiol. 2019. PMID: 31551955 Free PMC article.
-
Assessment of differences between DNA content of cell-cultured and freely suspended oocysts of Cryptosporidium parvum and their suitability as DNA standards in qPCR.Parasit Vectors. 2019 Dec 19;12(1):596. doi: 10.1186/s13071-019-3851-7. Parasit Vectors. 2019. PMID: 31856894 Free PMC article.
-
Transcriptome Profiling of Toxoplasma gondii-Infected Human Cerebromicrovascular Endothelial Cell Response to Treatment with Monensin.Microorganisms. 2020 Jun 4;8(6):842. doi: 10.3390/microorganisms8060842. Microorganisms. 2020. PMID: 32512820 Free PMC article.
-
Changes in the levels of Cryspovirus during in vitro development of Cryptosporidium parvum.Parasitol Res. 2015 Jun;114(6):2063-8. doi: 10.1007/s00436-015-4390-6. Epub 2015 Feb 24. Parasitol Res. 2015. PMID: 25704645
-
In vitro anthelmintic assessment of selected phytochemicals against Hymenolepis diminuta, a zoonotic tapeworm.J Parasit Dis. 2016 Sep;40(3):1082-6. doi: 10.1007/s12639-014-0560-1. Epub 2014 Sep 11. J Parasit Dis. 2016. PMID: 27605841 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous